放射组学分析预测胰腺导管内乳头状黏液性肿瘤恶性潜能:CT与MRI比较
纳入60例手术确诊的胰腺导管内乳头状黏液性肿瘤患者(37例恶性、23例良性),比较CT与MRI放射组学特征预测恶性潜能的表现。MRI放射组学特征可重复性高于CT,MRI放射组学模型AUC优于CT,且所有放射组学模型均优于基于2017年Fukuoka指南的临床影像模型。
要点
- MRI放射组学特征可重复性高于CT,无论动脉期或静脉期特征(均P<0.001)。
- MRI放射组学模型AUC:逻辑回归0.879、支持向量机0.940,高于CT模型的0.811和0.864。
- 所有放射组学模型预测表现均优于基于Fukuoka指南的临床影像模型(AUC=0.764)。
核心结论
- MRI放射组学模型因特征可重复性更高,预测胰腺导管内乳头状黏液性肿瘤恶性潜能的表现优于CT放射组学模型;放射组学模型表现优于基于Fukuoka指南的临床影像模型。
研究设计与样本
- 纳入60例手术确诊的胰腺导管内乳头状黏液性肿瘤患者(37例恶性、23例良性),从CT动脉期和静脉期图像及MRI T2加权图像提取放射组学特征,用组内相关系数评估观察者间可重复性,用最小绝对收缩和选择算子算法筛选特征,基于逻辑回归和支持向量机构建放射组学模型。
诊断标准与关键数值
- MRI放射组学模型AUC:逻辑回归0.879,支持向量机0.940。
- CT放射组学模型AUC:逻辑回归0.811,支持向量机0.864。
- 基于2017年Fukuoka指南的临床影像模型AUC=0.764。
- MRI放射组学特征可重复性高于CT放射组学特征,无论动脉期或静脉期特征(均P<0.001)。
临床应用与阅片要点
- 作者认为MRI放射组学模型预测胰腺导管内乳头状黏液性肿瘤恶性潜能的表现优于CT放射组学模型。
- 作者认为放射组学模型表现优于基于Fukuoka指南的临床影像模型。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: To compare the performance of CT and MRI radiomics for predicting the malignant potential of intraductal papillary mucinous neoplasms (IPMNs) of the pancreas, and to investigate their value compared to the revised 2017 international consensus Fukuoka guidelines.
MATERIALS AND METHODS: Sixty patients with surgically confirmed IPMNs (37 malignant and 23 benign) were included. Radiomics features were extracted from arterial and venous phase images of CT and T2-weighted images of MRI, respectively. Intraclass correlation coefficients for the radiomics features were calculated to assess the interobserver reproducibility. The least absolute shrinkage and selection operator algorithm was used for feature selection. Radiomics models were constructed based on selected features with logistic regression (LR) and support vector machine (SVM). A clinical and imaging model was constructed based on independent predictors of the revised 2017 Fukuoka guidelines determined in multivariate logistic regression with forward elimination.
RESULTS: The reproducibility of MRI radiomics features was higher than that of CT radiomics features, regardless of arterial or venous phase features (all p < 0.001). MRI radiomics models achieved improved AUCs (0.879 with LR and 0.940 with SVM, respectively), than that of CT radiomics models (0.811 with LR and 0.864 with SVM, respectively). All radiomics models provided better predictive performance than the clinical and imaging model (AUC = 0.764).
CONCLUSION: The MRI radiomics models with higher reproducibility radiomics features performed better than CT radiomics models for predicting the malignant potential of IPMNs. The performance of radiomics models was superior to the clinical and imaging model based on Fukuoka guidelines.
引用
- Cheng S, Shi H, Lu M, et al. Radiomics Analysis for Predicting Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison of CT and MRI. Acad Radiol. 2021. PMID: 34112528. doi:10.1016/j.acra.2021.04.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。